| |
| |
|
| Insider
Information: |
Bonvini Ezio |
| Relationship: |
Sr VP, Research & CSO |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
100,892 |
|
|
Indirect Shares
|
7,550 |
|
|
| Direct
Value |
$1,468,988 |
|
|
|
Indirect Value
|
$109,928 |
|
|
| Total
Shares |
108,442 |
|
|
| Total
Value |
$1,578,916 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Macrogenics Inc |
MGNX |
Sr VP, Research & CSO |
2024-02-22 |
100,892 |
2015-09-22 |
7,550 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2024-02-22 |
4 |
D |
$17.11 |
$160,252 |
D/D |
(9,366) |
100,892 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2024-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,125 |
110,258 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2024-02-15 |
4 |
D |
$17.40 |
$102,155 |
D/D |
(5,871) |
82,133 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2024-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,670 |
88,004 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2024-02-07 |
4 |
AS |
$18.00 |
$60,012 |
D/D |
(3,334) |
71,334 |
0 |
% |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2024-02-01 |
4 |
AS |
$15.00 |
$199,740 |
D/D |
(13,316) |
74,668 |
0 |
% |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2024-01-19 |
4 |
AS |
$12.00 |
$159,792 |
D/D |
(13,316) |
87,984 |
0 |
% |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2023-12-20 |
4 |
AS |
$10.08 |
$190,310 |
D/D |
(18,880) |
101,300 |
0 |
% |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2023-02-22 |
4 |
D |
$6.55 |
$23,704 |
D/D |
(3,619) |
120,180 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2023-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
123,799 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2022-05-14 |
4 |
D |
$4.16 |
$6,931 |
D/D |
(1,666) |
114,424 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2022-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
116,090 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2021-06-24 |
4 |
OE |
$16.00 |
$436,337 |
D/D |
26,076 |
108,550 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2021-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
84,890 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2021-05-14 |
4 |
D |
$29.49 |
$71,248 |
D/D |
(2,416) |
82,474 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2021-03-22 |
4 |
AS |
$32.00 |
$125,344 |
D/D |
(3,917) |
79,890 |
0 |
% |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2020-09-18 |
4 |
AS |
$32.00 |
$586,848 |
D/D |
(18,339) |
83,807 |
0 |
% |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2020-09-17 |
4 |
AS |
$29.88 |
$1,330,019 |
D/D |
(44,512) |
102,146 |
0 |
% |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2017-07-26 |
4 |
OE |
$0.94 |
$65,248 |
D/D |
53,264 |
146,658 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2016-10-19 |
4 |
OE |
$0.94 |
$5,028 |
D/D |
5,349 |
100,944 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2016-10-19 |
5 |
OE |
$0.94 |
$5,028 |
D/D |
5,349 |
93,394 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Sr VP, Research & CSO |
• – – |
2016-02-11 |
4 |
OE |
$0.94 |
$11,244 |
D/D |
11,962 |
95,595 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Senior VP, Research |
• – – |
2016-01-07 |
4 |
OE |
$0.94 |
$12,517 |
D/D |
13,316 |
83,633 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Senior VP, Research |
• – – |
2015-11-16 |
4 |
AS |
$31.44 |
$97,998 |
D/D |
(3,117) |
70,317 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Senior VP, Research |
• – – |
2015-10-15 |
4 |
AS |
$25.21 |
$157,134 |
D/D |
(6,233) |
73,434 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
